Insmed Inc Stock Investor Sentiment
| INSM Stock | USD 74.09 0.94 1.29% |
About 63% of all Insmed's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Insmed Inc suggests that some traders are interested. Insmed's investing sentiment overview a quick insight into current market opportunities from investing in Insmed Inc. Many technical investors use Insmed Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
63
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Insmed's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Insmed Inc.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentDisposing |
Insmed Historical Sentiment
Although Insmed's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Insmed, such as negative comments on social media and news outlets, may cause fear in the market and push Insmed's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Insmed.
Insmed |
Insmed Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Insmed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Insmed Inc Historical Investor Sentiment
Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Insmed news discussions. The higher the estimate score, the more favorable the investor's outlook on Insmed.
Far too much social signal, news, headlines, and media speculation about Insmed that are available to investors today. That information is available publicly through Insmed media outlets and privately through word of mouth or via Insmed internal channels. However, regardless of the origin, that massive amount of Insmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Insmed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insmed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insmed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insmed alpha.
Insmed Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 26969 shares by Flammer Martina M.d. of Insmed at 34.03 subject to Rule 16b-3 | 09/13/2024 |
2 | Disposition of 730 shares by Michael Smith of Insmed at 70.05 subject to Rule 16b-3 | 09/27/2024 |
3 | Should iShares Morningstar Small-Cap Growth ETF Be on Your Investing Radar | 09/30/2024 |
4 | Disposition of 11900 shares by Michael Smith of Insmed at 17.16 subject to Rule 16b-3 | 10/11/2024 |
5 | Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 | 10/17/2024 |
6 | Insmed Ranks No. 1 on Sciences 2024 Top Biopharma Employers List | 10/24/2024 |
7 | Insmed Q3 2024 Earnings Preview | 10/30/2024 |
8 | Decoding Insmed Inc A Strategic SWOT Insight | 11/01/2024 |
9 | Insmed To Present at November 2024 Investor Conferences | 11/06/2024 |
10 | Eversept Partners, LP Expands Stake in Community Health Systems Inc | 11/15/2024 |
11 | Suvretta Capital Managements Strategic Acquisition in Benitec Biopharma Inc | 11/19/2024 |
Check out Insmed Hype Analysis, Insmed Correlation and Insmed Performance. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.55) | Revenue Per Share 2.206 | Quarterly Revenue Growth 0.182 | Return On Assets (0.26) | Return On Equity (8.91) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.